Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Spatial differences in mortality are a significant source of inequality in low-mortality countries and are important for public health, regional planning, and subnational population forecasts. Long-term trends in geographic mortality inequalities remain poorly understood, especially from a comparative perspective. In this study, we examine trends in subnational mortality differences in France, Italy, and Spain from 1975 to 2019. We study whether life expectancy has converged or diverged between geographic areas, assess how the geographic mortality gradient has changed, and document age-specific differences. We find convergence in life expectancy in all three countries, although the path of convergence varies between countries and sexes. We find concerning evidence of diverging mortality at younger ages in all three countries. Our results show that even in similar national contexts, very different subnational trajectories in mortality inequalities can occur.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350882PMC
http://dx.doi.org/10.1007/s10680-025-09745-7DOI Listing

Publication Analysis

Top Keywords

france italy
8
italy spain
8
geographic mortality
8
mortality inequalities
8
life expectancy
8
three countries
8
mortality
7
spatial trends
4
trends mortality
4
mortality convergence
4

Similar Publications

Background: Parkinson's disease (PD) is characterized by motor symptoms altering gait domains such as slow walking speed, reduced step and stride length, and increased double support time. Gait disturbances occur in the early, mild to moderate, and advanced stages of the disease in both backward walking (BW) and forward walking (FW), but are more pronounced in BW. At this point, however, no information is available about BW performance and disease stages specified using the Hoehn and Yahr (H&Y) scale.

View Article and Find Full Text PDF

Beyond their classical functions as redox cofactors, recent fundamental and clinical research has expanded our understanding of the diverse roles of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) in signaling pathways, epigenetic regulation and energy homeostasis. Moreover, NAD and NADP influence numerous diseases as well as the processes of aging, and are emerging as targets for clinical intervention. Here, we summarize safety, bioavailability and efficacy data from NAD-related clinical trials, focusing on aging and neurodegenerative diseases.

View Article and Find Full Text PDF

Despite advances in genomic diagnostics, the majority of individuals with rare diseases remain without a confirmed genetic diagnosis. The rapid emergence of advanced omics technologies, such as long-read genome sequencing, optical genome mapping and multiomic profiling, has improved diagnostic yield but also substantially increased analytical and interpretational complexity. Addressing this complexity requires systematic multidisciplinary collaboration, as recently demonstrated by targeted diagnostic workshops.

View Article and Find Full Text PDF

Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.

Bone Marrow Transplant

September 2025

Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain.

For over two decades, the EBMT has updated recommendations on indications for haematopoietic cell transplantation (HCT) practice based on clinical and scientific developments in the field. This is the ninth special EBMT report on indications for HCT for haematological diseases, solid tumours and immune disorders. Our aim is to provide guidance on HCT indications according to prevailing clinical practice in EBMT countries and centres.

View Article and Find Full Text PDF